JPH0672899A - シクロペプチドおよび粘膜への適用時における吸収促進剤としてのその使用 - Google Patents

シクロペプチドおよび粘膜への適用時における吸収促進剤としてのその使用

Info

Publication number
JPH0672899A
JPH0672899A JP5122478A JP12247893A JPH0672899A JP H0672899 A JPH0672899 A JP H0672899A JP 5122478 A JP5122478 A JP 5122478A JP 12247893 A JP12247893 A JP 12247893A JP H0672899 A JPH0672899 A JP H0672899A
Authority
JP
Japan
Prior art keywords
peptide
formula
acceptable salt
basic
physiologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5122478A
Other languages
English (en)
Japanese (ja)
Inventor
Juergen Sandow
ユルゲン・ザンドウ
Walter Duerckheimer
ヴアルター・デユルクハイマー
Guenter Ditzinger
ギユンター・デイツインガー
Hans-Peter Merkle
ハンス−ペーター・メルクレ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of JPH0672899A publication Critical patent/JPH0672899A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP5122478A 1992-05-26 1993-05-25 シクロペプチドおよび粘膜への適用時における吸収促進剤としてのその使用 Pending JPH0672899A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4217350:7 1992-05-26
DE4217350 1992-05-26

Publications (1)

Publication Number Publication Date
JPH0672899A true JPH0672899A (ja) 1994-03-15

Family

ID=6459729

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5122478A Pending JPH0672899A (ja) 1992-05-26 1993-05-25 シクロペプチドおよび粘膜への適用時における吸収促進剤としてのその使用

Country Status (18)

Country Link
US (1) US5565423A (enExample)
EP (1) EP0571921B1 (enExample)
JP (1) JPH0672899A (enExample)
KR (1) KR940005669A (enExample)
AT (1) ATE144991T1 (enExample)
AU (1) AU665676B2 (enExample)
CA (1) CA2096889A1 (enExample)
DE (1) DE59304389D1 (enExample)
DK (1) DK0571921T3 (enExample)
ES (1) ES2096140T3 (enExample)
FI (1) FI932351A7 (enExample)
GR (1) GR3021570T3 (enExample)
HU (1) HUT64776A (enExample)
IL (1) IL105795A (enExample)
NO (1) NO931888L (enExample)
NZ (1) NZ247680A (enExample)
TW (1) TW274552B (enExample)
ZA (1) ZA933629B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005524649A (ja) * 2002-02-25 2005-08-18 カイロン コーポレーション Ｍｃ４−ｒアゴニストの鼻腔内投与
JP2018505868A (ja) * 2015-01-15 2018-03-01 ノーザン アンチバイオティクス オイ ポリミキシン誘導体およびその使用
WO2020196315A1 (ja) * 2019-03-25 2020-10-01 国立大学法人筑波大学 細胞層透過促進剤、薬剤吸収補助用組成物、及び医薬組成物

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US20080261933A1 (en) * 2007-04-23 2008-10-23 Jens Hoffmann Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases
CA2747995A1 (en) 2008-12-23 2010-07-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CA2855916A1 (en) 2011-11-18 2013-05-23 Novacta Biosystems Limited Polymyxin derivatives
KR102354902B1 (ko) 2013-05-22 2022-01-24 에버레스트 메디신즈 (싱가포르) 피티이. 리미티드 폴리믹신 유도체 및 상이한 항생제와의 조합 요법에 있어서의 이들의 용도
JP7349773B2 (ja) 2014-11-26 2023-09-25 スペロ・セラピューティクス・インコーポレーテッド 化合物
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
MA52946B1 (fr) 2018-06-25 2024-03-29 Spero Therapeutics Inc Composés
CN116332993A (zh) * 2023-03-13 2023-06-27 遵义医科大学 一种氨基噻唑肟酰胺类化合物及其制备方法和应用
CN117649950B (zh) * 2024-01-29 2024-05-17 北京大学第三医院（北京大学第三临床医学院） 一种催产素药物作用动力学模型及其构建方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2124060B1 (enExample) * 1971-02-02 1974-04-12 Rhone Poulenc Sa
AU7753787A (en) * 1986-08-06 1988-02-24 Jean-Luc Fauchere Production of covalent-linked conjugates from an antibiotic and a non-toxic derivative of polymyxine b
DE3726324A1 (de) * 1987-08-07 1989-02-16 Hoechst Ag Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute
US5177059A (en) * 1989-11-15 1993-01-05 Sandoz Ltd. Polymyxin B conjugates

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005524649A (ja) * 2002-02-25 2005-08-18 カイロン コーポレーション Ｍｃ４−ｒアゴニストの鼻腔内投与
JP2018505868A (ja) * 2015-01-15 2018-03-01 ノーザン アンチバイオティクス オイ ポリミキシン誘導体およびその使用
WO2020196315A1 (ja) * 2019-03-25 2020-10-01 国立大学法人筑波大学 細胞層透過促進剤、薬剤吸収補助用組成物、及び医薬組成物
JPWO2020196315A1 (ja) * 2019-03-25 2021-09-27 国立大学法人 筑波大学 細胞層透過促進剤、薬剤吸収補助用組成物、及び医薬組成物

Also Published As

Publication number Publication date
KR940005669A (ko) 1994-03-22
AU3876693A (en) 1993-12-02
AU665676B2 (en) 1996-01-11
HUT64776A (en) 1994-02-28
TW274552B (enExample) 1996-04-21
DK0571921T3 (da) 1997-04-01
EP0571921B1 (de) 1996-11-06
EP0571921A2 (de) 1993-12-01
HU9301520D0 (en) 1993-09-28
FI932351A7 (fi) 1993-11-27
FI932351A0 (fi) 1993-05-24
IL105795A (en) 1998-03-10
NO931888L (no) 1993-11-29
EP0571921A3 (enExample) 1994-01-12
ZA933629B (en) 1993-12-20
CA2096889A1 (en) 1993-11-27
ATE144991T1 (de) 1996-11-15
NZ247680A (en) 1995-07-26
DE59304389D1 (de) 1996-12-12
ES2096140T3 (es) 1997-03-01
GR3021570T3 (en) 1997-02-28
NO931888D0 (no) 1993-05-25
US5565423A (en) 1996-10-15
IL105795A0 (en) 1993-09-22

Similar Documents

Publication Publication Date Title
JPH0672899A (ja) シクロペプチドおよび粘膜への適用時における吸収促進剤としてのその使用
KR101021632B1 (ko) 성기능 장애 치료용 조성물 및 치료 방법
FI92326C (fi) LHRH:n nonapeptidi- ja dekapeptidianalogeja, jotka ovat käyttökelpoisia LHRH:n antagonisteina
JPH09507217A (ja) 成長ホルモン放出特性を持つ化合物
EP0490806A2 (en) Nasal pharmaceutical compositions
CZ291382B6 (cs) Peptidické deriváty ovlivňující uvolňování růstového hormonu, farmaceutický přípravek je obsahující a jejich použití
HU184704B (en) Process for preparing biologically active encephaline analogues
KR20120034642A (ko) 펩티드 및 펩티드?관련 화합물의 고침투성 전구약물 조성물
JPH04297497A (ja) ブラジキニン拮抗薬
JPS61122297A (ja) 新規ハロ低級アルキルグアニジノ置換アミノ酸化合物およびその製法
WO1995004540A1 (en) N-terminus modified analogs of lhrh
US6596728B1 (en) Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives, process for their preparation, pharmaceuticals comprising these compounds and their use
CA1331131C (en) Cyclic peptides as promoters of absorption on administration onto the mucosa
DK164109B (da) Lh-rh-antagonister og deres farmaceutisk acceptable syreadditionssalte og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende disse
EP0328090A2 (en) LHRH analogs
JPH0625068B2 (ja) 鼻腔内投与用組成物及びその製造方法
CA2167834A1 (en) N-terminus modified analogs of lhrh
JPWO1995018147A1 (ja) オーレオバシジン類
AU620184B2 (en) Competitive gonadoliberin antagonists
EP0301850A2 (en) LHRH antagonist analogs and 19-nor-progestational steroids for therapy
JPH10501807A (ja) 新規なオピオイドペプチドアンタゴニスト
JP2005089471A (ja) 環式ニュ−ロキニンａ拮抗剤
JPH0461880B2 (enExample)
JPS6289700A (ja) バソプレシン化合物
US20060160989A1 (en) Polypeptide useful as antiallergic/antiasthmatic activity, methods for the preparation thereof, pharmaceutical compositions containing such polypeptide and use thereof